BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting

Authors :: Funding Info: https://doi.org/10.1016/j.pathol.2021.11.002
Scolyer, Richard A.
Atkinson, Victoria
Gyorki, David E.
Lambie, Duncan
O'Toole, Sandra
Saw, Robyn P.M.
Amanuel, Benhur
Angel, Christopher M.
Button-Sloan, Alison E.
Carlino, Matteo S.
Ch'ng, Sydney
Colebatch, Andrew J.
Daneshvar, Dariush
Pires da Silva, Inês
Dawson, Tamara
Ferguson, Peter M.
Foster-Smith, Erwin
Fox, Stephen B.
Gill, Anthony J.
Gupta, Ruta
Henderson, Michael A.
Hong, Angela M.
Howle, Julie R.
Jackett, Louise A.
James, Craig
Lee, C. Soon
Funding Info: https://doi.org/10.1016/j.pathol.2021.11.002
Scolyer, Richard A.
Atkinson, Victoria
Gyorki, David E.
Lambie, Duncan
O'Toole, Sandra
Saw, Robyn P.M.
Amanuel, Benhur
Angel, Christopher M.
Button-Sloan, Alison E.
Carlino, Matteo S.
Ch'ng, Sydney
Colebatch, Andrew J.
Daneshvar, Dariush
Pires da Silva, Inês
Dawson, Tamara
Ferguson, Peter M.
Foster-Smith, Erwin
Fox, Stephen B.
Gill, Anthony J.
Gupta, Ruta
Henderson, Michael A.
Hong, Angela M.
Howle, Julie R.
Jackett, Louise A.
James, Craig
Lee, C. Soon
Source :: Pathology; 6
Abstract: Scolyer, R. A., Atkinson, V., Gyorki, D. E., Lambie, D., O'Toole, S., Saw, R. P., ... & Long, G. V. (2022). BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting. Pathology. https://doi.org/10.1016/j.pathol.2021.11.002</a>

Tools